Meridian Co., Ltd.

Meridian Co., Ltd.

March 14, 2005 09:00 ET

Meridian Receives FDA Approval for the Lapex-2000 a Low-Level Laser Therapy Device


NEWS RELEASE TRANSMITTED BY CCNMatthews

FOR: MERIDIAN CO., LTD.

OTC Bulletin Board SYMBOL: MRDAF

MARCH 14, 2005 - 09:00 ET

Meridian Receives FDA Approval for the Lapex-2000 a
Low-Level Laser Therapy Device

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - March 14, 2005) - Meridian
Co., Ltd. ("Meridian" or the "Company") (OTCBB:MRDAF), is very pleased
to receive FDA approval for its low-level laser therapy device, the
Lapex-2000.

More About: Lapex-2000

The Lapex-2000 uses low-level laser therapy ("LLLT"), which delivers a
laser light to various areas of the body without damaging the skin
tissue. The light source is placed in contact with the skin allowing the
photon energy to penetrate tissue. The body then coverts the photon
energy into biochemical energy by interacting with cellular structures
resulting in the restoration of normal cell function and enhancement of
the body's natural healing process. The Lapex-2000 is digitally
controlled with an LCD screen and is easy to operate.

The Lapex-2000 is approved for use in treating Carpal Tunnel Syndrome
("CTS"). LLLT has been used to effectively treat a variety of conditions
including rheumatoid arthritis, immune system disorders, sports
injuries, inflammations, Angina Pectoris, Cerebral infarction, fibroid
tissue and functional disorders in muscles, tendons and joints, as well
as increasing and improving blood supply. The Company believes its
product can greatly reduce the need for medication and surgery while
helping people towards a more active and less painful lifestyle.

To learn more about the Company's product line view Meridian's Interview
with the Chicago Stock Exchange - ItsAboutFinance.com - by clicking the
link below:

http://media4.streamtoyou.com/MRDAFDesc.wmv

More About: Low-Level Laser Therapy

Several conditions involving pain can be treated effectively with LLLT,
therefore the Company is anticipating that the Lapex-2000 will by a
major revenue source for 2005. There are a large number of pain
management specialists that would benefit from the use of Meridian's
high quality low-level laser therapy device, such as Physiotherapists,
Sports Medicine professionals, sports team coaches and trainers,
Chiropractors, Masseurs, and general practitioners.

More than 30 million people visited chiropractic doctors last year for a
variety of conditions, and more and more medical doctors are referring
their patients to chiropractic doctors. It is estimated that in 2010
there will be over 100,000 chiropractors in the United States, the 3rd
largest doctoral-level health care profession after medicine and
dentistry.

LLLT is one of today's most effective healing tools. Unlike many
therapies and drugs that just treat symptoms, LLLT has the ability to
actually promote and enhance healing. LLLT is the future of medicine and
is a modality that is rapidly growing in popularity throughout the world.

LLLT's Long Term Cumulative Effects

- ATP production is increased by increasing the number and productivity
of mitochondria resulting in improved cellular metabolism;

- Increased levels of serotonin production and endorphins (the body's
natural mood-enhancing and pain relief hormones);

- Regulates electrolyte balance

- Stimulates immune response

- Reduces inflammation by suppressing inflammatory enzymes that create
swelling, redness, pain, and heat and enhance the release of
anti-inflammatory enzymes;

- Enhances lymphatic drainage, which increases circulation, reduces
edema and speeds healing.

- Stimulates the healing process

- Release and production of growth hormone

More About: Meridian

Meridian is an established leader in the research/development,
manufacturing, and sales of integrative medical diagnostic equipment.
The company sells its products and equipment to a wide array of
customers in the global health care industry. The company presently
holds a total of 18 worldwide patents on its technology, and has
received FDA, as well as other international regulatory approvals for
many of its products.

Meridian is committed to the ongoing global research and advancement of
integrative medical products that contribute to the better health of
humanity.

-30-

Contact Information

  • FOR FURTHER INFORMATION PLEASE CONTACT:
    Optima Capital
    (403) 547-1576
    or
    Meridian Medical Inc.
    Debbie Williams
    President
    1-877-738-8119
    www.meridianmedical.ca/